Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2025-08-12
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study tests the feasibility and acceptability of Women on the Road to Health (WORTH) Promoting Access to Treatment, Health, and Support (Paths), a digital intervention adapted from the evidence-based CDC Best Practice HIV prevention intervention, Women on the Road to Health (WORTH), originally developed at Columbia University School of Social Work. WORTH Paths is designed to help reproductive-aged women in the criminal legal system with substance use disorders and unmet need for contraception reduce drug use and improve contraceptive use.
Participants (N=50) will be randomly assigned to one of two groups:
WORTH Paths Intervention Group - Participants will attend three virtual group sessions with facilitated videoconference sessions and self-paced digital activities focused on reducing drug use and increasing contraceptive use. They will also receive guidance on how to access and navigate health services.
Control Group - Participants will receive a virtual general wellness program that includes education on substance use and sexual and reproductive health but does not include skills-based training related to these topics. The focus will be on general wellness and stress reduction.
Both groups will receive resources for substance use treatment and sexual and reproductive health services.
Researchers will track changes in drug use and contraceptive use over three months. Participants will complete surveys and provide urine samples to confirm changes in drug use.
Primary aims:
Feasibility: Measured by session attendance, treatment completion, dropouts, and reasons for termination.
Acceptability: Measured by participant ease of use, helpfulness, and satisfaction.
Primary behavioral outcomes:
Self-reported drug use confirmed by urine drug tests. Contraceptive use, including initiation and consistent use.
Secondary behavioral outcome:
Linkage to substance use disorder treatment (measured by appointments made and sessions attended).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial
NCT01318538
Computer-based Brief Intervention for Perinatal Substance Abuse
NCT00685074
Harm Reduction Services
NCT05776316
The Women's Recovery Group Study: Stage I Trial
NCT00230100
Regional Partnership for Pregnant Women at Risk of Substance Misuse and Their Newborns
NCT03735212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While some existing programs for women in the criminal legal system focus on HIV prevention through condom use, fewer interventions take a comprehensive approach to sexual and reproductive health by addressing all forms of contraception while also integrating substance use treatment strategies.
This study tests WORTH Paths, a digital intervention designed to reduce drug use and increase contraceptive use. WORTH Paths builds on Women on the Road to Health (WORTH), an evidence-based CDC Best Practice HIV prevention intervention originally developed at the Columbia University School of Social Work. While WORTH has been effective in increasing condom use, this new adaptation expands its focus to a broader range of contraceptive methods and strategies to support women in reducing drug use.
Study Design
This study is a randomized controlled trial (RCT). Participants will be randomly assigned to one of two groups:
1. WORTH Paths Intervention Group
Participants in this group will receive the WORTH Paths program, a culturally tailored digital intervention designed to help women involved in the criminal legal system reduce substance use and improve contraceptive use. This intervention includes:
* Three virtual group sessions led by trained facilitators via videoconferencing
* Culturally relevant digital interactive activities, including animations, videos, and exercises to reinforce key skills
* Education on a full range of contraceptive methods, including long-acting reversible contraception (LARC), barrier methods, and other effective forms of contraception at reducing unintended pregnancy and sexually transmitted infections
* Guidance on accessing and navigating substance use treatment and reproductive healthcare services, including how to advocate for their needs within the healthcare system
* Cognitive-behavioral and motivational interviewing (MI)-based activities to help participants develop personalized strategies for reducing substance use and improving reproductive health behaviors
* Skill-building for self-regulation and behavioral strategies, including managing drug-related triggers, coping with relationship and environmental stressors, and setting personal health goals
* Safety planning and decision-making strategies, with a focus on reducing interpersonal risks such as intimate partner violence and reproductive coercion
* Participants in the intervention group will also receive resources for substance use treatment and sexual and reproductive health services, including referrals to local and online providers for contraception and substance use treatment.
2. Control Group (Wellness Program)
Participants in the control group will receive a general wellness program designed to provide support and education while excluding the behavioral skill-building components of the intervention. This program includes:
* Three virtual group sessions led by trained facilitators via videoconferencing
* Education about challenges in accessing substance use treatment and sexual and reproductive health services among women in the criminal legal system
* Guided mindfulness exercises, including meditation and relaxation techniques
* Stress management strategies, such as breathing exercises and coping mechanisms for managing emotional distress
* General wellness discussions on self-care and maintaining overall well-being
* Referrals and informational resources for substance use treatment and reproductive health services, but no structured training on how to navigate or advocate for care Unlike the intervention group, the control group will not receive training in behavioral change strategies related to substance use or contraceptive use.
Assessments \& Data Collection
All participants will complete:
* Baseline assessments and mail-in urine drug tests at enrollment
* Follow-up assessments and mail-in urine drug tests at 3 months
* Participants will report on drug use and contraceptive use through online surveys. Urine samples will biologically verify changes in drug use.
Eligibility Criteria
To participate, individuals must:
* Identify as a woman aged 18-44
* Have had criminal legal system involvement within the past year
* Meet DSM-5 criteria for current illicit substance use disorder as assessed by the Mini International Neuropsychiatric Interview (MINI)
* Have a past 30-day history of unmet need for contraception (not using contraception despite not wanting to become pregnant)
* Live in the New York metropolitan area (New York, New Jersey, or Connecticut)
Exclusion Criteria:
* Unable to give informed consent due to a medical condition or cognitive impairment
* Does not speak, read, or write in English
* Unwilling to follow study procedures Recruitment Methods
* Participants will be recruited through community-based organizations that serve formerly incarcerated women. Recruitment efforts will include:
Flyers and posters at community centers and shelters
* Announcements on community listservs
* Direct referrals from program staff
* Participation is completely voluntary, and participants may withdraw at any time. Privacy will be strictly protected.
Data Collection \& Safety Measures The study will use self-reported surveys and urine drug tests to measure changes in substance use.
Surveys will be completed securely online
* Data will be stored in a password-protected, encrypted system to ensure confidentiality
* Trained facilitators will monitor sessions and provide referrals if needed. If a participant experiences distress, they will be connected to counseling and substance use treatment resources.
Potential Benefits
While there is no guaranteed benefit, participants may:
* Gain new knowledge about contraception and reproductive health
* Receive support and strategies for reducing drug use and improving contraceptive use
* Obtain referrals for substance use treatment and sexual/reproductive health services (local and online)
* Improve self-efficacy and decision-making skills
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Intervention Group: Receives a digital intervention including facilitated group-based treatment via videoconference and interactive activities to reduce substance use and improve contraceptive use.
* Control Group: Receives a wellness intervention focusing on stress reduction, physical activity, and general health.
This is a pilot randomized controlled trial. The study will recruit 50 reproductive-aged women involved in criminal legal systems with substance use disorders and unmet need for contraception who will be randomly assigned to either the intervention (n=25) or the wellness control condition (n=25). Both arms involve facilitated group-based treatment via videoconference.
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WORTH Paths Digital Intervention Group
Participants will receive a culturally tailored program adapted for reproductive-aged women involved in the criminal legal system with substance use disorders and unmet contraceptive needs. The intervention consists of three facilitated group sessions over videoconference with digital interactive activities to support behavior change.
Key components include:
* Raising awareness about different contraceptive methods and substance use treatment options
* Discussing personal motivations for reducing drug use and using contraception
* Developing skills to identify and manage substance use and reproductive health triggers
* Digital interactive activities to reinforce learning and skill-building
* Practicing decision-making tools and goal-setting strategies
* Addressing barriers related to safety including intimate partner violence
* Creating a safety plan and strategies for maintaining progress
* Resources for state and online substance use and sexual/reproductive health services
WORTH Paths Digital Intervention
Participants in this arm will receive the WORTH Paths digital intervention, a culturally tailored program designed for women involved in the criminal legal system with substance use disorders and unmet contraceptive needs. The intervention consists of three facilitated group sessions over videoconference with digital interactive activities to support behavior change.
WORTH Paths Digital Wellness Group
Participants in this arm will receive the WORTH Paths Wellness Group, a wellness-focused intervention delivered via three facilitated group sessions over videoconference with digital interactive activities. Sessions cover general health, stress reduction, and navigating health services. Topics include education about substance use and sexual and reproductive health risks, guided meditation and mindfulness training, stress management techniques, and an overview of substance use and reproductive health services. Participants will also receive digital wellness resources, including recorded mindfulness exercises and links to online platforms for health services.
WORTH Paths Wellness Group
A wellness-focused intervention consisting of three facilitated group sessions over videoconference with digital interactive activities. Sessions cover general health, stress reduction, and navigating health services, including education about substance use and sexual/reproductive health risks, guided meditation, stress management techniques, and an overview of available health services. Participants also receive digital wellness resources, including recorded mindfulness exercises and links to online health service platforms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WORTH Paths Digital Intervention
Participants in this arm will receive the WORTH Paths digital intervention, a culturally tailored program designed for women involved in the criminal legal system with substance use disorders and unmet contraceptive needs. The intervention consists of three facilitated group sessions over videoconference with digital interactive activities to support behavior change.
WORTH Paths Wellness Group
A wellness-focused intervention consisting of three facilitated group sessions over videoconference with digital interactive activities. Sessions cover general health, stress reduction, and navigating health services, including education about substance use and sexual/reproductive health risks, guided meditation, stress management techniques, and an overview of available health services. Participants also receive digital wellness resources, including recorded mindfulness exercises and links to online health service platforms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-44 years
* Past year criminal legal involvement (e.g., incarceration or community supervision)
* Meets criteria for current substance use disorder (SUD) as defined by DSM-5 and assessed by the Mini-International Neuropsychiatric Interview (MINI)
* Meets criteria for unmet need for contraception (capable of pregnancy, sexually active, does not want to become pregnant within the next year, but is currently not using contraception)
* Able to read, write, and speak English
* Willing and able to provide informed consent
Exclusion Criteria
* Diagnosed infertility (e.g., menopause, tubal ligation, hysterectomy)
* Unable to provide informed consent due to significant cognitive impairment, mental health condition, or substance intoxication
* Unable or unwilling to meet study requirements (e.g., attend sessions, complete assessments)
18 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Fairleigh Dickinson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Slavin
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa N Slavin, PhD
Role: PRINCIPAL_INVESTIGATOR
Fairleigh Dickinson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fairleigh Dickinson University
Teaneck, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Annie J Rohan, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDU-K01-2022-MNS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.